Factors associated with aortic valve calcification in type 2 diabetes-a Steno INTEN-CT substudy.

Eur Heart J Cardiovasc ImagingSep 1, 2026
Clinical ResearchCardiologyEndocrinology

Amal Haujir, Preman Kumarathurai, Jacob Volmer Stidsen et al.

✦ AI-curated · Sources linked

In 30 seconds

This cross-sectional substudy of the Steno INTEN-CT trial examined factors linked to aortic valve calcification (AVC) in 4570 individuals with type 2 diabetes (T2D) aged 55-74. The study found that 46% had AVC > 0, with older age, higher BMI, hypertension, chronic kidney disease, and statin use associated with increased AVC.

Key findings

  • 46% of participants had AVC > 0.
  • Age was associated with higher AVC (OR per SD 1.54, 95% CI 1.43-1.66).
  • Statin use was linked to higher AVC (OR 1.50, 95% CI 1.27-1.78).
  • Higher LDL cholesterol had a stronger association with AVC in men (OR 1.39) than in women (OR 1.16).

Why it matters

Understanding the factors associated with AVC in T2D patients can help clinicians identify at-risk individuals and potentially guide monitoring and management strategies to mitigate cardiovascular risks.

Source

Published in Eur Heart J Cardiovasc Imaging. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Cardiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.